| Project/Area Number |
15K14992
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Environmental and hygienic pharmacy
|
|---|
| Research Institution | Tokyo University of Science |
|---|
Principal Investigator |
Kaji Toshiyuki 東京理科大学, 薬学部薬学科, 教授 (90204388)
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | バイオオルガノメタリクス / メタロチオネイン / 有機-無機ハイブリッド分子 / 誘導 / 血管内皮細胞 / 有機－無機ハイブリッド分子 |
|---|
| Outline of Final Research Achievements |
The present study revealed that induction of metallothionein (MT) isoforms MT-1 and MT-2 of vascular endothelial cells mediated by the MTF-1-MRE pathway and Nrf2-ARE pathway, respectively, using organic-inorganic hybrid molecules. Additionally, it was also revealed that induction of MT-1A and MT-2A is mediated by the ALK5-Smad2/Smad4-Sp1 pathway and ALK5-Smad2-Sp1pathway, respectively. It has been postulated that there is no functional difference between MT-1 and MT-2, however, the present results suggest the functional differentiation between the MT isoforms.
|
